Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
52 hedge funds and large institutions have $33.3M invested in Thorne Healthtech, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 16 closing their positions.
75% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 16
27% more funds holding
Funds holding: 41 → 52 (+11)
1.71% less ownership
Funds ownership: 11.92% → 10.21% (-1.7%)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
38% less capital invested
Capital invested by funds: $54.1M → $33.3M (-$20.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.01M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.96M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$1.92M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.61M |
| 5 |
BlackRock
New York
|
+$755K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$5.37M |
| 2 |
Millennium Management
New York
|
-$2.36M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$1.73M |
| 4 |
Blackstone Inc
New York
|
-$1.3M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.13M |
THRN Hedge Fund Activity: Q4 2021 in Review
52 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q4 2021, worth a combined $33.3M — down 38% from $54.1M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new THRN positions and 16 closed out — a net gain of 12 holders — while 8 added to existing stakes and 11 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $2.01M. The largest seller was Bank of America, cutting an estimated $5.37M.
- 52 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q4 2021, up from 41 in Q3 2021.
- Funds reported $33.3M of Thorne Healthtech, Inc. Common Stock stock for Q4 2021, down 38% quarter-over-quarter.
- 28 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q4 2021 and 16 closed out, a net change of +12 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q4 2021 was Renaissance Technologies, an estimated $2.01M added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q4 2021 was Bank of America, an estimated $5.37M sold.
Based on aggregated 13F filings for Q4 2021.